Carisma Therapeutics, Inc.
US ˙ NasdaqCM ˙ US14216R1014

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for JAFCO Super V3 Investment Limited Partnership. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at JAFCO Super V3 Investment Limited Partnership har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:TCON / TRACON Pharmaceuticals, Inc. 10% Owner 1.497.053
US:EBIO / Eleven Biotherapeutics, Inc. 10% Owner 1.923.226
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af JAFCO Super V3 Investment Limited Partnership. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb CARM / Carisma Therapeutics, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i CARM / Carisma Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2014-02-11 EBIO JAFCO Super V3 Investment Limited Partnership 219.790 10,0000 219.790 10,0000 2.197.900 730

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

CARM / Carisma Therapeutics, Inc. Insider Trades
Insidersalg CARM / Carisma Therapeutics, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i CARM / Carisma Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2015-05-08 EBIO JAFCO Super V3 Investment Limited Partnership 33.400 13,2300 33.400 13,2300 441.882 731
2015-02-02 EBIO JAFCO Super V3 Investment Limited Partnership 17.900 11,6200 17.900 11,6200 207.998
2015-01-30 EBIO JAFCO Super V3 Investment Limited Partnership 60.000 11,7700 60.000 11,7700 706.200
2015-01-29 EBIO JAFCO Super V3 Investment Limited Partnership 55.000 11,4600 55.000 11,4600 630.300
2015-01-28 EBIO JAFCO Super V3 Investment Limited Partnership 5.000 11,5800 5.000 11,5800 57.900
2015-01-27 EBIO JAFCO Super V3 Investment Limited Partnership 2.200 11,6600 2.200 11,6600 25.652
2015-01-26 EBIO JAFCO Super V3 Investment Limited Partnership 200 11,5000 200 11,5000 2.300
2015-01-26 EBIO JAFCO Super V3 Investment Limited Partnership 200 11,5300 200 11,5300 2.306
2015-01-26 EBIO JAFCO Super V3 Investment Limited Partnership 100 11,6800 100 11,6800 1.168
2015-01-26 EBIO JAFCO Super V3 Investment Limited Partnership 100 11,7700 100 11,7700 1.177
2015-01-26 EBIO JAFCO Super V3 Investment Limited Partnership 494 11,8800 494 11,8800 5.869
2015-01-26 EBIO JAFCO Super V3 Investment Limited Partnership 6 11,8100 6 11,8100 71
2015-01-26 EBIO JAFCO Super V3 Investment Limited Partnership 100 11,8200 100 11,8200 1.182
2015-01-26 EBIO JAFCO Super V3 Investment Limited Partnership 100 11,8700 100 11,8700 1.187
2015-01-23 EBIO JAFCO Super V3 Investment Limited Partnership 100 11,5700 100 11,5700 1.157
2015-01-23 EBIO JAFCO Super V3 Investment Limited Partnership 100 11,7000 100 11,7000 1.170
2015-01-23 EBIO JAFCO Super V3 Investment Limited Partnership 100 11,7600 100 11,7600 1.176
2015-01-23 EBIO JAFCO Super V3 Investment Limited Partnership 100 11,8600 100 11,8600 1.186
2015-01-23 EBIO JAFCO Super V3 Investment Limited Partnership 536 11,8700 536 11,8700 6.362
2015-01-23 EBIO JAFCO Super V3 Investment Limited Partnership 100 11,8800 100 11,8800 1.188
2015-01-23 EBIO JAFCO Super V3 Investment Limited Partnership 300 11,8900 300 11,8900 3.567
2015-01-23 EBIO JAFCO Super V3 Investment Limited Partnership 3.664 11,9000 3.664 11,9000 43.602
2015-01-22 EBIO JAFCO Super V3 Investment Limited Partnership 100 11,5800 100 11,5800 1.158
2015-01-22 EBIO JAFCO Super V3 Investment Limited Partnership 100 11,6000 100 11,6000 1.160
2015-01-22 EBIO JAFCO Super V3 Investment Limited Partnership 100 11,7350 100 11,7350 1.174
2015-01-22 EBIO JAFCO Super V3 Investment Limited Partnership 100 11,7550 100 11,7550 1.176
2015-01-22 EBIO JAFCO Super V3 Investment Limited Partnership 100 11,8600 100 11,8600 1.186
2015-01-22 EBIO JAFCO Super V3 Investment Limited Partnership 100 11,8700 100 11,8700 1.187
2015-01-22 EBIO JAFCO Super V3 Investment Limited Partnership 100 11,8750 100 11,8750 1.188
2015-01-22 EBIO JAFCO Super V3 Investment Limited Partnership 2.600 11,8800 2.600 11,8800 30.888
2015-01-22 EBIO JAFCO Super V3 Investment Limited Partnership 300 11,8900 300 11,8900 3.567
2015-01-22 EBIO JAFCO Super V3 Investment Limited Partnership 83 11,9000 83 11,9000 988
2015-01-22 EBIO JAFCO Super V3 Investment Limited Partnership 100 11,9350 100 11,9350 1.194
2015-01-22 EBIO JAFCO Super V3 Investment Limited Partnership 100 11,9400 100 11,9400 1.194
2015-01-22 EBIO JAFCO Super V3 Investment Limited Partnership 100 11,9800 100 11,9800 1.198
2015-01-22 EBIO JAFCO Super V3 Investment Limited Partnership 1.017 11,9900 1.017 11,9900 12.194
2015-01-21 EBIO JAFCO Super V3 Investment Limited Partnership 700 11,5000 700 11,5000 8.050
2015-01-21 EBIO JAFCO Super V3 Investment Limited Partnership 200 11,5150 200 11,5150 2.303
2015-01-21 EBIO JAFCO Super V3 Investment Limited Partnership 100 11,6600 100 11,6600 1.166
2015-01-21 EBIO JAFCO Super V3 Investment Limited Partnership 100 11,6800 100 11,6800 1.168
2015-01-21 EBIO JAFCO Super V3 Investment Limited Partnership 100 11,7100 100 11,7100 1.171
2015-01-21 EBIO JAFCO Super V3 Investment Limited Partnership 100 11,8300 100 11,8300 1.183
2015-01-16 EBIO JAFCO Super V3 Investment Limited Partnership 4.100 12,0000 4.100 12,0000 49.200
2015-01-16 EBIO JAFCO Super V3 Investment Limited Partnership 100 12,0050 100 12,0050 1.200
2015-01-16 EBIO JAFCO Super V3 Investment Limited Partnership 100 12,0100 100 12,0100 1.201
2015-01-16 EBIO JAFCO Super V3 Investment Limited Partnership 100 12,0400 100 12,0400 1.204
2015-01-15 EBIO JAFCO Super V3 Investment Limited Partnership 700 12,0000 700 12,0000 8.400
2015-01-15 EBIO JAFCO Super V3 Investment Limited Partnership 99 12,1900 99 12,1900 1.207
2015-01-15 EBIO JAFCO Super V3 Investment Limited Partnership 1 12,2500 1 12,2500 12
2015-01-15 EBIO JAFCO Super V3 Investment Limited Partnership 100 12,3000 100 12,3000 1.230
2015-01-15 EBIO JAFCO Super V3 Investment Limited Partnership 800 12,5000 800 12,5000 10.000
2015-01-13 EBIO JAFCO Super V3 Investment Limited Partnership 100 12,2600 100 12,2600 1.226
2015-01-13 EBIO JAFCO Super V3 Investment Limited Partnership 100 12,3250 100 12,3250 1.232
2015-01-13 EBIO JAFCO Super V3 Investment Limited Partnership 100 12,3300 100 12,3300 1.233
2015-01-13 EBIO JAFCO Super V3 Investment Limited Partnership 31 12,4100 31 12,4100 385
2015-01-13 EBIO JAFCO Super V3 Investment Limited Partnership 500 12,4300 500 12,4300 6.215
2015-01-13 EBIO JAFCO Super V3 Investment Limited Partnership 145 12,4400 145 12,4400 1.804
2015-01-13 EBIO JAFCO Super V3 Investment Limited Partnership 200 12,4450 200 12,4450 2.489
2015-01-13 EBIO JAFCO Super V3 Investment Limited Partnership 100 12,4600 100 12,4600 1.246
2015-01-13 EBIO JAFCO Super V3 Investment Limited Partnership 200 12,4800 200 12,4800 2.496
2015-01-13 EBIO JAFCO Super V3 Investment Limited Partnership 551 12,5000 551 12,5000 6.888
2015-01-13 EBIO JAFCO Super V3 Investment Limited Partnership 249 12,5100 249 12,5100 3.115
2015-01-13 EBIO JAFCO Super V3 Investment Limited Partnership 1.382 12,5200 1.382 12,5200 17.303
2015-01-13 EBIO JAFCO Super V3 Investment Limited Partnership 242 12,5300 242 12,5300 3.032
2015-01-13 EBIO JAFCO Super V3 Investment Limited Partnership 100 12,5400 100 12,5400 1.254
2015-01-13 EBIO JAFCO Super V3 Investment Limited Partnership 100 12,5450 100 12,5450 1.254
2014-08-26 EBIO JAFCO Super V3 Investment Limited Partnership 1.000 11,5700 1.000 11,5700 11.570
2014-08-25 EBIO JAFCO Super V3 Investment Limited Partnership 1.000 11,5000 1.000 11,5000 11.500
2014-08-20 EBIO JAFCO Super V3 Investment Limited Partnership 165 11,5000 165 11,5000 1.898
2014-08-19 EBIO JAFCO Super V3 Investment Limited Partnership 1.000 11,5500 1.000 11,5500 11.550
2014-08-18 EBIO JAFCO Super V3 Investment Limited Partnership 1.000 11,8700 1.000 11,8700 11.870
2014-08-15 EBIO JAFCO Super V3 Investment Limited Partnership 800 11,6100 800 11,6100 9.288
2014-08-15 EBIO JAFCO Super V3 Investment Limited Partnership 100 11,7700 100 11,7700 1.177
2014-08-15 EBIO JAFCO Super V3 Investment Limited Partnership 100 11,5000 100 11,5000 1.150
2014-08-15 EBIO JAFCO Super V3 Investment Limited Partnership 100 12,0400 100 12,0400 1.204
2014-08-15 EBIO JAFCO Super V3 Investment Limited Partnership 200 12,0250 200 12,0250 2.405
2014-08-15 EBIO JAFCO Super V3 Investment Limited Partnership 300 12,0000 300 12,0000 3.600
2014-08-14 EBIO JAFCO Super V3 Investment Limited Partnership 995 11,5000 995 11,5000 11.442
2014-08-14 EBIO JAFCO Super V3 Investment Limited Partnership 5 11,6100 5 11,6100 58
2014-08-13 EBIO JAFCO Super V3 Investment Limited Partnership 1.000 12,0000 1.000 12,0000 12.000

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

CARM / Carisma Therapeutics, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af JAFCO Super V3 Investment Limited Partnership som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2015-10-19 2015-10-16 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock
S - Sale -1.500 1.497.053 -0,10 9,90 -14.848 14.819.328
2015-10-15 2015-10-15 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock
S - Sale -5.300 1.498.553 -0,35 10,16 -53.826 15.219.154
2015-10-13 2015-10-13 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock
S - Sale -1.720 1.503.853 -0,11 10,01 -17.224 15.059.133
2015-10-13 2015-10-09 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock
S - Sale -1.448 1.505.573 -0,10 10,01 -14.487 15.063.408
2015-10-08 2015-10-08 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock
S - Sale -9.632 1.507.021 -0,64 10,11 -97.372 15.234.777
2015-10-08 2015-10-07 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock
S - Sale -12.288 1.516.653 -0,80 10,09 -124.003 15.305.152
2015-10-06 2015-10-05 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock
S - Sale -8.800 1.528.941 -0,57 10,10 -88.850 15.437.106
2015-10-06 2015-10-02 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock
S - Sale -6.300 1.537.741 -0,41 10,06 -63.406 15.476.441
2015-09-29 2015-09-25 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock
S - Sale -7.600 1.544.041 -0,49 12,13 -92.164 18.724.276
2015-09-24 2015-09-24 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock
S - Sale -5.403 1.551.641 -0,35 12,55 -67.791 19.468.440
2015-09-24 2015-09-23 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock
S - Sale -16.900 1.557.044 -1,07 13,13 -221.954 20.449.282
2015-09-22 2015-09-22 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock
S - Sale -21.226 1.573.944 -1,33 13,63 -289.217 21.445.931
2015-09-22 2015-09-21 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock
S - Sale -3.200 1.595.170 -0,20 15,45 -49.432 24.641.229
2015-09-22 2015-09-21 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock
S - Sale -15.000 1.598.370 -0,93 14,27 -214.088 22.812.736
2015-09-17 2015-09-17 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock
S - Sale -19.492 1.613.370 -1,19 11,76 -229.282 18.977.910
2015-09-17 2015-09-16 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock
S - Sale -5.552 1.632.862 -0,34 11,84 -65.763 19.341.087
2015-09-17 2015-09-15 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock
S - Sale -17.300 1.638.414 -1,04 11,79 -203.882 19.308.873
2015-09-14 2015-09-14 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock
S - Sale -22.000 1.655.714 -1,31 11,86 -260.920 19.636.768
2015-09-14 2015-09-11 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock
S - Sale -19.438 1.677.714 -1,15 11,96 -232.478 20.065.459
2015-09-14 2015-09-10 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock
S - Sale -6.500 1.697.152 -0,38 11,94 -77.610 20.263.995
2015-09-14 2015-09-10 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock
S - Sale -12.100 1.703.652 -0,71 11,24 -136.004 19.149.048
2015-09-09 2015-09-09 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock
S - Sale -12.000 1.715.752 -0,69 10,71 -128.543 18.378.964
2015-09-09 2015-09-08 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock
S - Sale -5.700 1.727.752 -0,33 10,47 -59.704 18.097.166
2015-09-09 2015-09-04 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock
S - Sale -6.600 1.733.452 -0,38 10,48 -69.162 18.165.017
2015-09-03 2015-09-03 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock
S - Sale -8.000 1.740.052 -0,46 10,49 -83.895 18.247.751
2015-09-03 2015-09-02 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock
S - Sale -7.300 1.748.052 -0,42 10,54 -76.943 18.424.818
2015-09-01 2015-09-01 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock
S - Sale -8.000 1.755.352 -0,45 10,41 -83.314 18.280.762
2015-09-01 2015-08-31 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock
S - Sale -6.000 1.763.352 -0,34 10,44 -62.623 18.404.457
2015-08-25 2015-08-24 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock
S - Sale -3.000 1.769.352 -0,17 11,00 -33.000 19.462.872
2015-08-20 2015-08-20 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock
S - Sale -1.683 1.772.352 -0,09 11,14 -18.747 19.742.052
2015-08-20 2015-08-19 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock
S - Sale -9.000 1.774.035 -0,50 11,40 -102.644 20.232.692
2015-08-18 2015-08-18 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock
S - Sale -1.000 1.783.035 -0,06 11,53 -11.527 20.553.044
2015-08-18 2015-08-17 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock
S - Sale -3.600 1.784.035 -0,20 11,75 -42.307 20.965.979
2015-08-18 2015-08-14 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock
S - Sale -6.574 1.787.635 -0,37 11,71 -76.977 20.931.955
2015-08-14 2015-08-13 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock
S - Sale -6.061 1.794.209 -0,34 11,57 -70.126 20.758.998
2015-08-14 2015-08-12 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock
S - Sale -3.300 1.800.270 -0,18 11,65 -38.445 20.973.146
2015-08-12 2015-08-12 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock
S - Sale -3.000 1.803.570 -0,17 11,40 -34.212 20.567.912
2015-08-12 2015-08-11 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock
S - Sale -2.800 1.806.570 -0,15 11,40 -31.934 20.603.931
2015-08-11 2015-08-10 4/A TCON Tracon Pharmaceuticals, Inc.
Common Stock
S - Sale -6.000 1.809.370 -0,33 11,50 -69.000 20.807.755
2015-08-11 2015-08-07 4/A TCON Tracon Pharmaceuticals, Inc.
Common Stock
S - Sale -2.300 1.815.370 -0,13 11,83 -27.209 21.475.827
2015-08-10 2015-08-10 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock
S - Sale -6.000 1.551.420 -0,39 11,50 -69.000 17.841.330
2015-08-10 2015-08-07 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock
S - Sale -2.300 1.557.420 -0,15 11,83 -27.209 18.424.279
2015-05-11 2015-05-08 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -33.400 1.923.226 -1,71 13,23 -441.882 25.444.280
2015-02-17 2015-02-04 4/A TCON Tracon Pharmaceuticals, Inc.
Common Stock
P - Purchase 257.950 1.817.670 16,54 10,00 2.579.500 18.176.700
2015-02-09 2015-01-27 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -2.200 1.956.626 -0,11 11,66 -25.652 22.814.259
2015-02-05 2015-02-04 4 TCON Tracon Pharmaceuticals, Inc.
Series B Redeemable Convertible Preferred Stock
C - Conversion -1.036.120 0 -100,00
2015-02-05 2015-02-04 4 TCON Tracon Pharmaceuticals, Inc.
Series A Redeemable Convertible Preferred Stock
C - Conversion -5.000.000 0 -100,00
2015-02-05 2015-02-04 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock
C - Conversion 1.559.720 1.559.720
2015-02-03 2015-02-02 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -17.900 1.958.826 -0,91 11,62 -207.998 22.761.558
2015-01-30 2015-01-30 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -60.000 1.976.726 -2,95 11,77 -706.200 23.266.065
2015-01-30 2015-01-29 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -55.000 2.036.726 -2,63 11,46 -630.300 23.340.880
2015-01-30 2015-01-28 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -5.000 2.091.726 -0,24 11,58 -57.900 24.222.187
2015-01-26 2015-01-26 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -100 2.096.726 0,00 11,87 -1.187 24.888.138
2015-01-26 2015-01-26 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -100 2.096.826 0,00 11,82 -1.182 24.784.483
2015-01-26 2015-01-26 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -6 2.096.926 0,00 11,81 -71 24.764.696
2015-01-26 2015-01-26 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -494 2.096.932 -0,02 11,88 -5.869 24.911.552
2015-01-26 2015-01-26 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -100 2.097.426 0,00 11,77 -1.177 24.686.704
2015-01-26 2015-01-26 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -100 2.097.526 0,00 11,68 -1.168 24.499.104
2015-01-26 2015-01-26 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -200 2.097.626 -0,01 11,53 -2.306 24.185.628
2015-01-26 2015-01-26 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -200 2.097.826 -0,01 11,50 -2.300 24.124.999
2015-01-26 2015-01-23 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -3.664 2.098.026 -0,17 11,90 -43.602 24.966.509
2015-01-26 2015-01-23 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -300 2.101.690 -0,01 11,89 -3.567 24.989.094
2015-01-26 2015-01-23 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -100 2.101.990 0,00 11,88 -1.188 24.971.641
2015-01-26 2015-01-23 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -536 2.102.090 -0,03 11,87 -6.362 24.951.808
2015-01-26 2015-01-23 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -100 2.102.626 0,00 11,86 -1.186 24.937.144
2015-01-26 2015-01-23 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -100 2.102.726 0,00 11,76 -1.176 24.728.058
2015-01-26 2015-01-23 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -100 2.102.826 0,00 11,70 -1.170 24.603.064
2015-01-26 2015-01-23 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -100 2.102.926 0,00 11,57 -1.157 24.330.854
2015-01-23 2015-01-22 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -1.017 2.103.026 -0,05 11,99 -12.194 25.215.282
2015-01-23 2015-01-22 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -100 2.104.043 0,00 11,98 -1.198 25.206.435
2015-01-23 2015-01-22 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -100 2.104.143 0,00 11,94 -1.194 25.123.467
2015-01-23 2015-01-22 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -100 2.104.243 0,00 11,94 -1.194 25.114.140
2015-01-23 2015-01-22 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -83 2.104.343 0,00 11,90 -988 25.041.682
2015-01-23 2015-01-22 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -300 2.104.426 -0,01 11,89 -3.567 25.021.625
2015-01-23 2015-01-22 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -2.600 2.104.726 -0,12 11,88 -30.888 25.004.145
2015-01-23 2015-01-22 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -100 2.107.326 0,00 11,88 -1.188 25.024.496
2015-01-23 2015-01-22 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -100 2.107.426 0,00 11,87 -1.187 25.015.147
2015-01-23 2015-01-22 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -100 2.107.526 0,00 11,86 -1.186 24.995.258
2015-01-23 2015-01-22 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -100 2.107.626 0,00 11,76 -1.176 24.775.144
2015-01-23 2015-01-22 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -100 2.107.726 0,00 11,74 -1.174 24.734.165
2015-01-23 2015-01-22 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -100 2.107.826 0,00 11,60 -1.160 24.450.782
2015-01-23 2015-01-22 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -100 2.107.926 0,00 11,58 -1.158 24.409.783
2015-01-23 2015-01-21 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -100 2.108.026 0,00 11,83 -1.183 24.937.948
2015-01-23 2015-01-21 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -100 2.108.126 0,00 11,71 -1.171 24.686.155
2015-01-23 2015-01-21 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -100 2.108.226 0,00 11,68 -1.168 24.624.080
2015-01-23 2015-01-21 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -100 2.108.326 0,00 11,66 -1.166 24.583.081
2015-01-23 2015-01-21 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -200 2.108.426 -0,01 11,52 -2.303 24.278.525
2015-01-23 2015-01-21 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -700 2.108.626 -0,03 11,50 -8.050 24.249.199
2015-01-20 2015-01-16 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -100 2.109.326 0,00 12,04 -1.204 25.396.285
2015-01-20 2015-01-16 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -100 2.109.426 0,00 12,01 -1.201 25.334.206
2015-01-20 2015-01-16 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -100 2.109.526 0,00 12,00 -1.200 25.324.860
2015-01-20 2015-01-16 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -4.100 2.109.626 -0,19 12,00 -49.200 25.315.512
2015-01-20 2015-01-15 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -800 2.113.726 -0,04 12,50 -10.000 26.421.575
2015-01-20 2015-01-15 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -100 2.114.526 0,00 12,30 -1.230 26.008.670
2015-01-20 2015-01-15 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -1 2.114.626 0,00 12,25 -12 25.904.168
2015-01-20 2015-01-15 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -99 2.114.627 0,00 12,19 -1.207 25.777.303
2015-01-20 2015-01-15 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -700 2.114.726 -0,03 12,00 -8.400 25.376.712
2015-01-15 2015-01-13 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -100 2.115.426 0,00 12,54 -1.254 26.538.019
2015-01-15 2015-01-13 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -100 2.115.526 0,00 12,54 -1.254 26.528.696
2015-01-15 2015-01-13 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -242 2.115.626 -0,01 12,53 -3.032 26.508.794
2015-01-15 2015-01-13 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -1.382 2.115.868 -0,07 12,52 -17.303 26.490.667
2015-01-15 2015-01-13 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -249 2.117.250 -0,01 12,51 -3.115 26.486.798
2015-01-15 2015-01-13 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -551 2.117.499 -0,03 12,50 -6.888 26.468.738
2015-01-15 2015-01-13 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -200 2.118.050 -0,01 12,48 -2.496 26.433.264
2015-01-15 2015-01-13 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -100 2.118.250 0,00 12,46 -1.246 26.393.395
2015-01-15 2015-01-13 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -200 2.118.350 -0,01 12,44 -2.489 26.362.866
2015-01-15 2015-01-13 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -145 2.118.550 -0,01 12,44 -1.804 26.354.762
2015-01-15 2015-01-13 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -500 2.118.695 -0,02 12,43 -6.215 26.335.379
2015-01-15 2015-01-13 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -31 2.119.195 0,00 12,41 -385 26.299.210
2015-01-15 2015-01-13 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -100 2.119.226 0,00 12,33 -1.233 26.130.057
2015-01-15 2015-01-13 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -100 2.119.326 0,00 12,32 -1.232 26.120.693
2015-01-15 2015-01-13 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -100 2.119.426 0,00 12,26 -1.226 25.984.163
2014-08-27 2014-08-26 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -1.000 2.119.526 -0,05 11,57 -11.570 24.522.916
2014-08-27 2014-08-25 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -1.000 2.120.526 -0,05 11,50 -11.500 24.386.049
2014-08-21 2014-08-20 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -165 2.121.526 -0,01 11,50 -1.898 24.397.549
2014-08-21 2014-08-19 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -1.000 2.121.691 -0,05 11,55 -11.550 24.505.531
2014-08-19 2014-08-18 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -1.000 2.122.691 -0,05 11,87 -11.870 25.196.342
2014-08-19 2014-08-15 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -300 2.123.691 -0,01 12,00 -3.600 25.484.292
2014-08-19 2014-08-15 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -200 2.123.991 -0,01 12,02 -2.405 25.540.992
2014-08-19 2014-08-15 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -100 2.124.191 0,00 12,04 -1.204 25.575.260
2014-08-19 2014-08-15 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -100 2.124.291 0,00 11,50 -1.150 24.429.346
2014-08-19 2014-08-15 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -100 2.124.391 0,00 11,77 -1.177 25.004.082
2014-08-19 2014-08-15 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -800 2.124.491 -0,04 11,61 -9.288 24.665.341
2014-08-15 2014-08-14 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -5 2.125.291 0,00 11,61 -58 24.674.629
2014-08-15 2014-08-14 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -995 2.125.296 -0,05 11,50 -11.442 24.440.904
2014-08-15 2014-08-13 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -1.000 2.126.291 -0,05 12,00 -12.000 25.515.492
2014-02-12 2014-02-11 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock Warrant (right to purchase)
M - Exercise -39.994 0 -100,00
2014-02-12 2014-02-11 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock Warrant (right to purchase)
M - Exercise -61.242 0 -100,00
2014-02-12 2014-02-11 4 EBIO Eleven Biotherapeutics, Inc.
Series B Preferred Stock
C - Conversion -232.105 0 -100,00
2014-02-12 2014-02-11 4 EBIO Eleven Biotherapeutics, Inc.
Series A Preferred Stock
C - Conversion -1.574.803 0 -100,00
2014-02-12 2014-02-11 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
M - Exercise 39.740 2.127.291 1,90
2014-02-12 2014-02-11 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
M - Exercise 60.853 2.087.551 3,00
2014-02-12 2014-02-11 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
C - Conversion 232.105 2.026.698 12,93
2014-02-12 2014-02-11 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
C - Conversion 1.574.803 1.794.593 716,50
2014-02-12 2014-02-11 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
P - Purchase 219.790 219.790 10,00 2.197.900 2.197.900
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)